Mather Group
CVS icon

Mather Group’s CVS Health CVS Stock Holding History

Mather Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08M Buy
12,575
+2,087
+20% +$204K 0.01% 358
2026
Q2 		$1.09M Buy
10,488
+787
+8% +$70.2K 0.01% 365
2026
Q1 		$697K Buy
9,701
+4,113
+74% +$317K 0.01% 416
2025
Q4 		$443K Buy
5,588
+840
+18% +$66.2K ﹤0.01% 435
2025
Q3 		$358K Buy
+4,748
New +$325K ﹤0.01% 467
2025
Q2 		– Sell
-2,893
Closed -$196K – 864
2025
Q1 		$196K Buy
2,893
+108
+4% +$6.46K ﹤0.01% 597
2024
Q4 		$125K Sell
2,785
-682
-20% -$38.3K ﹤0.01% 692
2024
Q3 		$218K Sell
3,467
-8,121
-70% -$474K ﹤0.01% 546
2024
Q2 		$924K Buy
11,588
+3,512
+43% +$220K 0.01% 277
2024
Q1 		$638K Sell
8,076
-9
-0.1% -$687 0.01% 289
2023
Q4 		$638K Buy
8,085
+2,181
+37% +$155K 0.01% 296
2023
Q3 		$412K Buy
5,904
+120
+2% +$8.5K 0.01% 367
2023
Q2 		$400K Sell
5,784
-4,459
-44% -$317K 0.01% 396
2023
Q1 		$761K Sell
10,243
-664
-6% -$55.7K 0.01% 254
2022
Q4 		$1.02M Sell
10,907
-414
-4% -$39.9K 0.02% 210
2022
Q3 		$1.08M Buy
11,321
+546
+5% +$54K 0.02% 185
2022
Q2 		$998K Buy
10,775
+80
+0.7% +$7.81K 0.02% 184
2022
Q1 		$1.08M Buy
10,695
+8
+0.1% +$840 0.02% 162
2021
Q4 		$1.1M Buy
10,687
+7,726
+261% +$714K 0.02% 143
2021
Q3 		$251K Sell
2,961
-45
-1% -$3.77K 0.01% 243
2021
Q2 		$251K Buy
3,006
+13
+0.4% +$1.06K 0.01% 238
2021
Q1 		$225K Buy
2,993
+13
+0.4% +$947 0.01% 238
2020
Q4 		$204K Sell
2,980
-480
-14% -$31.2K 0.01% 238
2020
Q3 		$202K Buy
+3,460
New +$215K 0.01% 231
2020
Q1 		– Sell
-2,898
Closed -$215K – 149
2019
Q4 		$215K Buy
+2,898
New +$203K 0.01% 158

Other funds holding CVS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Mather Group's CVS Position: Q3 2026 in Review

Mather Group increased its CVS Health (CVS) stake by 20% in Q3 2026, buying an estimated $204K and bringing the position to 12,575 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #358.

Mather Group first reported a position in CVS in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.1M in Q4 2021. 495 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Mather Group held 12,575 shares of CVS Health worth $1.08M as of Q3 2026.
  • Mather Group bought 2,087 CVS Health shares in Q3 2026, an estimated $204K.
  • CVS Health made up 0.01% of Mather Group's portfolio in Q3 2026, its #358 holding.
  • Mather Group first reported a position in CVS Health in Q4 2019 and has held it in 25 quarters since.
  • Mather Group's CVS Health position peaked at $1.1M in Q4 2021.
  • 495 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.